documents: FDA-2026-N-3447-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2026-N-3447-0001 FDA FDA-2026-N-3447 Notice of Approval of Product Under Voucher: Rare Pediatric Disease Priority Review Voucher; MNEXSPIKE (COVID–19 Vaccine, mRNA) Notice Notice of Approval 2026-04-16T04:00:00Z 2026 4     2026-04-16T18:06:41Z 2026-07371 0 0 09000064b92866e5

Links from other tables